table of content
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Drugs Overall Market Size
2.1 Global Gene Therapy Drugs Market Size: 2022 VS 2029
2.2 Global Gene Therapy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy Drugs Players in Global Market
3.2 Top Global Gene Therapy Drugs Companies Ranked by Revenue
3.3 Global Gene Therapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy Drugs Market Size Markets, 2022 & 2029
4.1.2 Neuromuscular Disease
4.1.3 Genetic Disease
4.1.4 Other
4.2 By Type - Global Gene Therapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Gene Therapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapy Drugs Revenue, 2018-2029
6.3.2 US Gene Therapy Drugs Market Size, 2018-2029
6.3.3 Canada Gene Therapy Drugs Market Size, 2018-2029
6.3.4 Mexico Gene Therapy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapy Drugs Revenue, 2018-2029
6.4.2 Germany Gene Therapy Drugs Market Size, 2018-2029
6.4.3 France Gene Therapy Drugs Market Size, 2018-2029
6.4.4 U.K. Gene Therapy Drugs Market Size, 2018-2029
6.4.5 Italy Gene Therapy Drugs Market Size, 2018-2029
6.4.6 Russia Gene Therapy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapy Drugs Market Size, 2018-2029
6.4.8 Benelux Gene Therapy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapy Drugs Revenue, 2018-2029
6.5.2 China Gene Therapy Drugs Market Size, 2018-2029
6.5.3 Japan Gene Therapy Drugs Market Size, 2018-2029
6.5.4 South Korea Gene Therapy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapy Drugs Market Size, 2018-2029
6.5.6 India Gene Therapy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapy Drugs Revenue, 2018-2029
6.6.2 Brazil Gene Therapy Drugs Market Size, 2018-2029
6.6.3 Argentina Gene Therapy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy Drugs Revenue, 2018-2029
6.7.2 Turkey Gene Therapy Drugs Market Size, 2018-2029
6.7.3 Israel Gene Therapy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapy Drugs Market Size, 2018-2029
6.7.5 UAE Gene Therapy Drugs Market Size, 2018-2029
7 Gene Therapy Drugs Companies Profiles
7.1 F. Hoffmann-La Roche AG
7.1.1 F. Hoffmann-La Roche AG Company Summary
7.1.2 F. Hoffmann-La Roche AG Business Overview
7.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Major Product Offerings
7.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.2 Novartis International AG
7.2.1 Novartis International AG Company Summary
7.2.2 Novartis International AG Business Overview
7.2.3 Novartis International AG Gene Therapy Drugs Major Product Offerings
7.2.4 Novartis International AG Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis International AG Key News & Latest Developments
7.3 Gilead Sciences, Inc.
7.3.1 Gilead Sciences, Inc. Company Summary
7.3.2 Gilead Sciences, Inc. Business Overview
7.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Major Product Offerings
7.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences, Inc. Key News & Latest Developments
7.4 Ultragenyx Pharmaceutical?Inc.
7.4.1 Ultragenyx Pharmaceutical?Inc. Company Summary
7.4.2 Ultragenyx Pharmaceutical?Inc. Business Overview
7.4.3 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Major Product Offerings
7.4.4 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.4.5 Ultragenyx Pharmaceutical?Inc. Key News & Latest Developments
7.5 Applied Genetic Technologies Corp
7.5.1 Applied Genetic Technologies Corp Company Summary
7.5.2 Applied Genetic Technologies Corp Business Overview
7.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Major Product Offerings
7.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.5.5 Applied Genetic Technologies Corp Key News & Latest Developments
7.6 Audentes Therapeutics
7.6.1 Audentes Therapeutics Company Summary
7.6.2 Audentes Therapeutics Business Overview
7.6.3 Audentes Therapeutics Gene Therapy Drugs Major Product Offerings
7.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.6.5 Audentes Therapeutics Key News & Latest Developments
7.7 BioMarin Pharmaceutical
7.7.1 BioMarin Pharmaceutical Company Summary
7.7.2 BioMarin Pharmaceutical Business Overview
7.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Major Product Offerings
7.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.7.5 BioMarin Pharmaceutical Key News & Latest Developments
7.8 Bluebird Bio
7.8.1 Bluebird Bio Company Summary
7.8.2 Bluebird Bio Business Overview
7.8.3 Bluebird Bio Gene Therapy Drugs Major Product Offerings
7.8.4 Bluebird Bio Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.8.5 Bluebird Bio Key News & Latest Developments
7.9 Nightstar Therapeutics
7.9.1 Nightstar Therapeutics Company Summary
7.9.2 Nightstar Therapeutics Business Overview
7.9.3 Nightstar Therapeutics Gene Therapy Drugs Major Product Offerings
7.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.9.5 Nightstar Therapeutics Key News & Latest Developments
7.10 Sangamo Therapeutics
7.10.1 Sangamo Therapeutics Company Summary
7.10.2 Sangamo Therapeutics Business Overview
7.10.3 Sangamo Therapeutics Gene Therapy Drugs Major Product Offerings
7.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.10.5 Sangamo Therapeutics Key News & Latest Developments
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Company Summary
7.11.2 Spark Therapeutics Business Overview
7.11.3 Spark Therapeutics Gene Therapy Drugs Major Product Offerings
7.11.4 Spark Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.11.5 Spark Therapeutics Key News & Latest Developments
7.12 uniQure
7.12.1 uniQure Company Summary
7.12.2 uniQure Business Overview
7.12.3 uniQure Gene Therapy Drugs Major Product Offerings
7.12.4 uniQure Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.12.5 uniQure Key News & Latest Developments
7.13 VBL Therapeutics
7.13.1 VBL Therapeutics Company Summary
7.13.2 VBL Therapeutics Business Overview
7.13.3 VBL Therapeutics Gene Therapy Drugs Major Product Offerings
7.13.4 VBL Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.13.5 VBL Therapeutics Key News & Latest Developments
7.14 Voyager Therapeutics
7.14.1 Voyager Therapeutics Company Summary
7.14.2 Voyager Therapeutics Business Overview
7.14.3 Voyager Therapeutics Gene Therapy Drugs Major Product Offerings
7.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue in Global Market (2018-2023)
7.14.5 Voyager Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
